Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study

Stavanger University Hospital, Department of Internal Medicine, PO Box 8100, N-4068 Stavanger, Norway.
Annals of the rheumatic diseases (Impact Factor: 9.27). 10/2008; 68(10):1541-6. DOI: 10.1136/ard.2008.098301
Source: PubMed

ABSTRACT To compare the prevalence and pattern of neuropsychiatric (NP) syndromes observed in systemic lupus erythematosus (SLE) to patients with Primary Sjögren syndrome (PSS) using the American College of Rheumatology (ACR) criteria for the 19 NP syndromes seen in SLE.
A population-based study was conducted including 68 patients with SLE (mean (SD) age 43.8 (13.6) years) and 72 with PSS (age 57.8 (13.0) years). Specialists in internal medicine, neurology and neuropsychology performed standardised examinations. Cerebral MRI scans and neurophysiological studies were performed in all patients.
Similar prevalences in SLE and PSS were observed for headaches (87% vs 78%, p = 0.165), cognitive dysfunction (46% vs 50%, p = 0.273), mood disorders (26% vs 33%, p = 0.376), anxiety disorders (12% vs 4%, p = 0.095), cranial neuropathy (1% vs 4%, p = 0.339) and seizure disorders (7% vs 3%, p = 0.208). Cerebrovascular disease was more common in SLE than PSS (12% vs 3%, p = 0.049); but mononeuropathy (0% vs 8%, p = 0.015) and polyneuropathy (18% vs 56%, p<0.001) were less common in SLE than PSS. Other syndromes were rare or absent in both patient groups.
Headache, cognitive dysfunction and mood disorders are common in both diseases, but otherwise there are distinct differences in NP involvement, with cerebrovascular diseases more prevalent in SLE and neuropathies more common in PSS. This indicates that some NP disease mechanisms are shared while others differ between the two diseases.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Primary Sjögren's syndrome (PSS) is a frequent systemic autoimmune disease. In this study, we aimed to explore the cognitive impairment and the correlations with brain MRI. Methods. Twenty-five patients (mean age 55 ± 11.8 years, 21 females) with PSS were prospectively selected and tested with a French translation of the Brief Repeatable Battery for Neuropsychological Examination. The results were compared with the scores for 25 matched patients with multiple sclerosis (MS) and 25 controls. Brain lesions were assessed by brain MRI using the Wahlund classification. Results. Fifteen of the 25 PSS patients (60%) presented with cognitive disorders versus 19/25 MS patients (76%). Five patients had dementia in the PSS group. Speed of information processing, attention, immediate and long-term memory, and executive functions were frequently impaired. The mean duration of cognitive complaints was 5.6 ± 6.1 years, and the mean duration of PSS was 15.8 ± 14.0 years. A trend towards a correlation was found between the severity of cognitive impairment and the degree of white matter lesions (WML) (P = 0.03, rho = 0.43). Conclusion. Cognitive impairment-mild or dementia-exists in patients with PSS. Further MRI studies are needed to better understand the precise neural basis of cognitive impairment in PSS patients.
    09/2013; 2013:501327. DOI:10.1155/2013/501327
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fatigue is a prominent symptom in many rheumatic diseases. Numerous factors contribute to cause fatigue, which can be a source of frustration for the patients and physicians, as the treatment often fails to produce the desired improvement. Diagnostic guidelines direct insufficient attention to the various semiological patterns of fatigue seen in rheumatic diseases. This update describes three main patterns of fatigue, depending on whether the source is physical or mental: muscle weakness in patients with neuromuscular disease; asthenia related to organic disease with excessive energy expenditure, deficient energy production (e.g., endocrine disorders), or inadequate recovery; and weariness due to the impact of stress and depression on quality of life. The prevalence of each pattern in various rheumatic diseases is discussed. This update underlines the practical benefits provided by a detailed semiological analysis of fatigue in patients with rheumatic disease and emphasizes the marked predominance of weariness due to stress and depression, on which the personality of the patient and inadequacy of social support systems may exert a major influence. Serotonin reuptake inhibitors (SSRIs) may be valuable in patients with fatigue not only because they improve the mental status, but also via their recently demonstrated anti-inflammatory effects.
    Joint, bone, spine: revue du rhumatisme 03/2011; 78(2):156-60. DOI:10.1016/j.jbspin.2010.05.002 · 3.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: La fatigue est un symptôme majeur dans les maladies rhumatismales, d’origine multifactorielle. Sa prise en charge est frustrante, aussi bien pour les médecins que pour les malades, dont l’attente n’est souvent pas satisfaite. Les guides de procédure diagnostique n’ont pas suffisamment pris en compte les caractéristiques sémiologiques des différents types de fatigue recensés dans les affections rhumatismales. Dans cette mise au point, nous proposons de décrire les différents aspects de la fatigue dans les maladies rhumatismales, de les classer en trois catégories en fonction de leur origine physique ou mentale : faiblesse musculaire en cas de désordres neuromusculaires ; asthénie en cas de perturbations organiques liées soit à une dépense d’énergie excessive, soit à une défaillance des systèmes producteurs d’énergie (glandes endocrines) ou à un défaut de récupération, et lassitude consécutive à l’impact du stress et de la dépression sur la qualité de la vie, et d’étudier la prévalence de chaque type dans les différentes maladies rhumatismales. Cette mise au point illustre le bénéfice pratique d’une approche de la fatigue des maladies rhumatismales centrée sur la sémiologie et souligne la forte prédominance de la lassitude liée au stress et à la dépression, dans laquelle les traits de personnalité des patients et l’insuffisance du support social pourraient jouer un rôle modulateur majeur. Les inhibiteurs de la recapture de la sérotonine (IRS) pourraient avoir un rôle thérapeutique majeur, non seulement pour leur action sur les désordres mentaux, mais aussi pour leurs propriétés anti-inflammatoires nouvellement démontrées.
    Revue du Rhumatisme 12/2010; 77(6):563-567. DOI:10.1016/j.rhum.2010.04.032